Clinical Trial Update: Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lesigercept for adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamines; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Lesigercept (Lesigercept)

Snippet

Sponsor: Yuhan Corporation | Conditions: Allergic Diseases, Chronic Spontaneous Urticaria (CSU) | Phase 2 | Status: RECRUITING